Abstract Details
|
Kristin P. Karpowicz
PRESENTER |
Ms. Karpowicz has nothing to disclose. |
| Catherine Carvelli, RN | Ms. Carvelli has nothing to disclose. |
| Emily Houston, BS (The University of Vermont Medical Center) | Ms. Houston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for F. Hoffmann-La Roche Ltd. |
| Andrew Solomon, MD, FAAN | Dr. Solomon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Solomon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech/Roche . Dr. Solomon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kiniksa Pharmaceuticals . Dr. Solomon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Solomon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Solomon has received research support from Bristol Meyers Squibb. |